Consistently, loss of function mouse models demonstrated that Dnmt3a, Dnmt3b, and Tet2 are tumor suppressors in a variety of hematologic malignancies including T- and B-cell lymphomas17–23. This evidence concerns the gene DNMT3B and neoplasm.